Delivery Order SPE2DB22D3401-SPE2DB24FT4VK

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $67K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $12,955.49 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 30-count packages of the pharmaceutical drug Vraylar 1.5 mg capsules, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $2,212.01, is for the supply of 4.5 mg Vraylar capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Vraylar 1.5 mg capsules. The contract has a ceiling value of $10,036.85 and is a Firm Fixed Price Delivery Order, with a completion date of May 21, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,705.67 firm fixed-price contract is for the supply of 4,565,683,431 units of the prescription drug Vraylar 3 mg capsules. The contract has a period of performance through September 5, 2024 and does not utilize any set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at up to $4,432.25, is for the delivery of Vraylar 1.5 mg capsules. It is a firm fixed price delivery order contract with a completion date of July 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vraylar 3 mg capsules. The $6,022.12 Firm Fixed Price contract has a completion date of November 12, 2024 and was awarded on November 8, 2024. The contract is a Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,198.60 firm fixed-price delivery order is for the supply of 4566132500 Vraylar 1.5 mg capsules. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,807.31 firm fixed-price contract is for the delivery of the prescription medication Vraylar 1.5 mg capsules. The contract has a completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Vraylar 3 mg capsules. The contract has a ceiling value of $2,764.57 and runs through June 13, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $32,794.35 firm-fixed-price contract is for the supply of the prescription drug Vraylar in 3 mg capsules. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT4VK
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $67,237.41 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of 4,565,891,746 units of the medication Vraylar 3 mg capsules. This contract has an ultimate completion date of September 23, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to provide a comprehensive range of pharmaceutical and medical supplies to support federal healthcare programs and facilities. This contract award did not utilize a set-aside designation.

Generated 12/20/24, 9:12 AM